MWR
NVS icon

McAdams Wright Ragen’s Novartis NVS Stock Holding History

McAdams Wright Ragen’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$855K Sell
10,138
-107
-1% -$8.66K 0.05% 210
2014
Q2 		$831K Hold
10,245
– – 0.05% 205
2014
Q1 		$780K Buy
10,245
+56
+0.5% +$4.08K 0.05% 200
2013
Q4 		$733K Buy
10,189
+4,735
+87% +$329K 0.05% 208
2013
Q3 		$375K Buy
5,454
+61
+1% +$4.04K 0.03% 243
2013
Q2 		$342K Buy
+5,393
New +$351K 0.03% 256

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McAdams Wright Ragen's NVS Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Novartis (NVS) stake by 1% in Q3 2014, selling an estimated $8.66K and leaving 10,138 shares worth $855K. The position accounts for 0.05% of the portfolio, ranked #210.

McAdams Wright Ragen first reported a position in NVS in Q2 2013 and has held it in 6 quarters since. 874 funds tracked by Wall St. Rank hold NVS as of Q3 2014.

  • McAdams Wright Ragen held 10,138 shares of Novartis worth $855K as of Q3 2014.
  • McAdams Wright Ragen sold 107 Novartis shares in Q3 2014, an estimated $8.66K.
  • Novartis made up 0.05% of McAdams Wright Ragen's portfolio in Q3 2014, its #210 holding.
  • McAdams Wright Ragen first reported a position in Novartis in Q2 2013 and has held it in 6 quarters since.
  • 874 funds tracked by Wall St. Rank held Novartis as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.